As per the research report, the size of the North America Collagen and Gelatin Market is valued at USD 2.23 billion in 2023 and estimated to be growing at a CAGR of 8.9%, to reach USD 3.41 billion by 2028 during the forecast period 2023 to 2028.
Gelatin is a translucent and brittle substance which is derived from collagen. It is used as a gelling agent in the food industry and in the production of various drugs. Collagen is the main protein in the connective tissues of animals. It makes up for about 35% of the total body protein content.
Increased prevalence of chronic diseases, rising geriatric population and the widespread use of gelatin and collagen in regenerative medicine is driving the market growth. Collagen is being used in various drugs and medical devices which in turn is driving the market growth. Collagen is also being used for wound healing which is stimulating the growth of the market. However, collagen obtained from bovine and porcine sources carry the risk of disease transmission which is acting as a restraint to the market growth.
This research report segmented and sub-segmented into the following categories:
The Collagen and Gelatin market was dominated by North America due to high number cases of diabetes and cardiovascular diseases.
Companies playing a dominant role in the North America Collagen and Gelatin Market profiled in this report are LifeSciences Holding Corporation (U.S.), Collagen Solutions plc (U.K.), Vornia Biomaterials, Ltd. (Ireland), Collagen Matrix, Inc. (U.S.), GELITA AG (Germany), Nitta Gelatin, Inc. (Japan), and PB Gelatin (Belgium), Royal DSM (Netherlands), Integra SYMATESE (France), and NuCollagen, LLC. (U.S.).
Related Reports
Access the study in MULTIPLE FORMATS
Purchase options starting from $ 1400
Didn’t find what you’re looking for?
TALK TO OUR ANALYST TEAM
Need something within your budget?
NO WORRIES! WE GOT YOU COVERED!
Call us on: +1 888 702 9696 (U.S Toll Free)
Write to us: [email protected]
Reports By Region